Sanofi Pasteur Logo
 
PRESCRIBE SKLICE (ivermectin) LOTION 0.5%
A prescription product indicated for the topical treatment of head lice1
Indicated for use on children 6 months of age and older1
Sklice Lotion should be used in the context of an overall lice management program.
Please see below for additional Important Safety Information for Sklice Lotion.

Prescribing Information Highlights

Please see full Prescribing Information for complete details on product information.

Sklice Lotion Dosage and Administration1

  • For topical use only. Not for oral, ophthalmic or intravaginal use.
  • Apply Sklice Lotion to dry hair in an amount sufficient (up to 1 tube) to thoroughly coat the hair and scalp.
  • After 10 minutes, rinse off with water.
  • The tube is intended for single use. Discard any unused portion.
  • Avoid contact with eyes.

Sklice Lotion Dosage Forms and Strengths1

Topical Lotion: 0.5%

Sklice Lotion Contraindications1

None

Sklice Lotion Warnings and Precautions1

Accidental ingestion in pediatric patients may occur. Administer only under direct adult supervision.

Most common adverse reactions (incidence <1%) are conjunctivitis, ocular hyperemia, eye irritation, dandruff, dry skin, and skin burning sensation.

To report SUSPECTED ADVERSE REACTIONS, contact Sanofi Pasteur Inc. at 1-800-835-3592 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

See Section 17 of the Prescribing Information for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling.

Indication:

Sklice Lotion is a pediculicide indicated for the topical treatment of head lice infestations in patients 6 months of age and older.

Adjunctive Measures:

Sklice Lotion should be used in the context of an overall lice management program:

  • Wash (in hot water) or dry-clean all recently worn clothing, hats, used bedding and towels.
  • Wash personal care items such as combs, brushes and hair clips in hot water.

A fine tooth comb or special nit comb may be used to remove dead lice and nits.

Important Safety Information For Sklice Lotion:

In order to prevent accidental ingestion, Sklice Lotion should only be administered to pediatric patients under the direct supervision of an adult.

The most common adverse reactions (incidence <1%) were conjunctivitis, ocular hyperemia, eye irritation, dandruff, dry skin, and skin burning sensation.

Before administering Sklice Lotion, please see the full Prescribing Information.

References

  1. Sklice Lotion [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc.; 2012.

PLEASE NOTE

By clicking on this link, you will be leaving this Sanofi Pasteur Web site and going to another, entirely independent Web site. Sanofi Pasteur provides this link as a service to its Web site visitors; however, it takes no responsibility for the information presented on any Web site but its own.

This link has opened in a new window. To return to your original site, please close this new window.

Click here to go to the page you requested. Close window and return to site.